Challenging diagnosis of granulomatosis after switching mepolizumab by dupilumab for severe asthma - 06/06/23
Doi : 10.1016/j.resmer.2022.100959
Lea Covarel a, Heloise Pina b, Pascale Martin c, Elodie Lellig d, Jean Staentzel a, Luc Groshaeny a, Thomas Moulinet e, Cecile Rumeau f, Fabien Pontille e, Philippe Campoli b, Pierre Vaillant a, Angelica Tiotiu a, g, ⁎ 
a Department of Pulmonology, University Hospital of Nancy, Nancy, France
b Department of Anatomopathology, University Hospital of Nancy, Nancy, France
c Department of Pulmonology, Hospital Robert Schuman, Metz, France
d Department of Dermatology, University Hospital of Nancy, Nancy, France
e Department of Internal Medicine, University Hospital of Nancy, Nancy, France
f ENT Department, University Hospital of Nancy, Nancy, France
g EA 3450 DevAH, Development, Adaptation, Cardio-Respiratory Regulations and Motor Control, University of Lorraine, Nancy, France
⁎Corresponding author at: Department of Pulmonology, University Hospital of Nancy, 9 Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.Department of PulmonologyUniversity Hospital of Nancy9 Rue du MorvanVandoeuvre-les-Nancy54500France
Le texte complet de cet article est disponible en PDF.
Plan
| Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. |
© 2022
SPLF and Elsevier Masson SAS. Tous droits réservés.
Vol 83
Article 100959- juin 2023 Retour au numéro
Article précédent
- Comparison of two pregnancies with and without elexacaftor-tezacaftor-ivacaftor in a woman with cystic fibrosis
- Matthieu Chamagne, Clémence Farabet, Dominique Grenet, Jean Marc Ayoubi
- Omalizumab effectiveness is independent of Staphylococcal Enterotoxin sensitization
- Nicolas Migueres, Anh Poirot, Nan Zhang, Claus Bachert, Frédéric de Blay
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?